In this episode, Michelle starts by introducing the day's topics before diving into Meta AI's latest research updates and new models, shedding light on their potential impact. She then discusses OpenAI's introduction of new safeguards and efforts to engage with the community, emphasizing the importance of AI safety. The episode also covers the national security implications and data siphoning concerns associated with DeepSeek's technology. Additionally, Michelle explores the partnership between BigHat Biosciences and Eli Lilly, focusing on advancements in precision medicine. The episode wraps up with closing remarks and a reminder for listeners to subscribe for more AI news updates.

(0:00) Introduction to today's episode

(0:33) Meta AI's research updates and new models

(3:12) OpenAI's new safeguards and community engagement

(5:40) DeepSeek's national security implications and data siphoning issues

(7:53) BigHat Biosciences and Eli Lilly partnership for precision medicine

(9:31) Closing remarks and subscription reminder